The nine-valent cervical cancer vaccine is available in China.On April 28, 2018, the State Drug Administration approved that the nine-valent HPV vaccine for the prevention of cervical cancer is available in China. More and more women are undergoing preventive vaccination against cervical cancer through preventive vaccination. The nine-valent vaccine is suitable for younger women, aged 16-26 years old or women without a history of sexual intercourse. In the past, the nine-valent cervical cancer vaccine needed to be administered in Hong Kong, but now the nine-valent cervical cancer vaccine is available in the domestic market, so women of appropriate age or without a history of sexual intercourse can also receive the nine-valent cervical cancer vaccine for cervical cancer prevention in China. However, after receiving the nine-valent cervical cancer vaccine, regular cervical cancer screenings are still required.